“SOLUBLE ST2 AND CD163 AS POTENTIALBIOMARKERS TO DIFFERENTIATE PRIMARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS FROM MACROPHAGE ACTIVATION SYNDROME”. 2019. Mediterranean Journal of Hematology and Infectious Diseases 11 (1): e2019008. https://doi.org/10.4084/mjhid.2019.008.